What are research peptides?

Research peptides are short chains of amino acids — the same building blocks as proteins — synthesized in laboratory settings for use in scientific investigations. Unlike larger protein therapeutics, peptides are typically 2–50 amino acids in length, which confers unique pharmacokinetic properties including targeted receptor binding, relatively rapid degradation, and low immunogenicity. Preclinical studies explore their roles in signaling pathways across metabolic, regenerative, and neuroendocrine systems.

What is BPC-157 and what biological mechanisms have been studied?

BPC-157 (Body Protective Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Research has examined its effects on angiogenesis, nitric oxide synthesis, and growth factor receptor modulation. Proposed mechanisms include upregulation of vascular endothelial growth factor (VEGF), interaction with the NO-system to promote vasodilation, and modulation of the dopaminergic and serotonergic neurotransmitter systems. Preclinical studies across rodent models report accelerated tendon-to-bone healing, muscle injury repair, and gastroprotective effects.

What is MOTS-c and how does it relate to mitochondrial signaling?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome. It activates AMP-activated protein kinase (AMPK), a central energy-sensing enzyme. Research in mouse models has shown that MOTS-c administration improves insulin sensitivity, reduces high-fat-diet-induced obesity, and extends median lifespan in aged mice. Circulating MOTS-c levels decline with age in humans, making it a subject of longevity research.

What is SS-31 and what is its proposed role in mitochondrial membrane protection?

SS-31 (elamipretide) is a tetrapeptide that selectively partitions into the inner mitochondrial membrane and binds cardiolipin — a lipid essential for cristae structure and the organization of respiratory chain supercomplexes — thereby reducing electron leak, superoxide generation, and cytochrome c release. Animal models of heart failure and ischemia-reperfusion injury have demonstrated improvements in ATP production and reductions in oxidative stress with SS-31 treatment.

What is Retatrutide and what receptor systems does it target?

Retatrutide (LY3437943) is a tri-agonist peptide that activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. Published phase 2 clinical trial data (NEJM, 2023) reported mean body-weight reductions of approximately 17% over 24 weeks at the highest dose studied.

What is the CJC-1295 + Ipamorelin combination and why are they studied together?

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that significantly extends its plasma half-life by forming a covalent bond with albumin. Ipamorelin is a selective growth hormone secretagogue receptor (GHSR) agonist that stimulates pituitary GH release through a separate receptor pathway. Combining GHRH analog and GHSR agonist targets both primary regulatory inputs to pituitary somatotrophs, producing synergistic GH pulses in preclinical studies while maintaining physiological pulsatility.

How are synthetic peptides stored to maintain stability?

Lyophilized (freeze-dried) peptides are the most stable form for long-term storage. In powder form, most synthetic peptides remain stable for 12–24 months when stored at −20 °C in a desiccated, light-protected environment. Reconstitution with sterile bacteriostatic water — which contains 0.9% benzyl alcohol as a preservative — allows repeated use from a single vial over several weeks when refrigerated at 2–8 °C.

TB-500 (Thymosin Beta-4): Research Overview

Q: What is a Certificate of Analysis (COA)?

A Certificate of Analysis is a document issued by an accredited analytical laboratory confirming the identity, purity, and potency of a synthesized compound. For research peptides, a COA typically includes HPLC chromatograms, mass spectrometry data, amino acid composition analysis, and solubility data. Independent third-party COAs — generated by labs with no financial relationship to the supplier — are considered the gold standard for verifying compound quality in preclinical research.

Q: What is TB-500 (Thymosin Beta-4) and how does it relate to actin dynamics?

TB-500 is a synthetic version of the 43-amino acid peptide Thymosin Beta-4 (Tβ4), one of the most abundant peptides in mammalian cells. Its primary structural role is the sequestration of globular actin (G-actin), which regulates actin polymerization dynamics essential for cell migration, proliferation, and wound healing. Research has demonstrated that Tβ4 promotes the migration of keratinocytes and endothelial cells into wound sites, stimulates angiogenesis, and reduces inflammation via down-regulation of NF-κB signaling.

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide that is one of the most abundant peptides in mammalian cells. It is studied for its central role in actin regulation, cell migration, and tissue repair.

Actin regulation and cell migration

The defining biological function of Thymosin Beta-4 is the sequestration of globular actin (G-actin), which regulates the polymerization dynamics essential to the cytoskeleton. By controlling the pool of available actin monomers, Tβ4 influences cell migration, proliferation, and structural reorganization during wound healing. This actin-sequestering role is what distinguishes TB-500 mechanistically from other tissue-repair peptides.

Tissue repair and angiogenesis research

Preclinical research has demonstrated that Tβ4 promotes the migration of keratinocytes and endothelial cells into wound sites, stimulates angiogenesis, and reduces inflammation through down-regulation of nuclear factor kappa-B (NF-κB) signaling. Animal studies report accelerated dermal wound closure, corneal healing, and — in cardiac injury models — activation of epicardial progenitor cells. These findings come from animal and in vitro models.

Why it is studied alongside BPC-157

TB-500 and BPC-157 are frequently studied together because their proposed mechanisms appear complementary: BPC-157 acts largely through NO-system modulation and VEGF-mediated angiogenesis, while TB-500 operates through actin sequestration and cell migration. Animal studies of the combination suggest additive effects on tendon healing and wound closure relative to either peptide alone, though controlled human data for the combination are absent from the published literature.

Purity and verification

Pokai Research TB-500 is third-party tested by Freedom Diagnostics Testing at 99.22% purity (batch 26030330). The batch-specific COA is available on the product page and independently verifiable via the published Freedom Diagnostics search code.

Frequently asked questions

What is TB-500 (Thymosin Beta-4) and how does it relate to actin dynamics?

TB-500 is a synthetic version of Thymosin Beta-4, one of the most abundant peptides in mammalian cells. It regulates actin polymerization, which drives cell migration and wound healing. Research shows it promotes keratinocyte and endothelial cell migration, stimulates angiogenesis, and reduces inflammation in preclinical models.

Source: Ann N Y Acad Sci (2012) · PubMed

What is the rationale for combining BPC-157 with TB-500?

BPC-157 and Thymosin Beta-4 (TB-500) are hypothesized to have complementary mechanisms in preclinical tissue-repair models. BPC-157 primarily exerts effects via NO-system modulation and VEGF-mediated angiogenesis, while Tβ4 operates through actin sequestration, cell migration promotion, and anti-inflammatory NF-κB suppression. Animal studies evaluating the combination suggest additive effects on tendon healing and wound closure that exceed either peptide alone. This synergy hypothesis has driven interest in combination formulations for preclinical musculoskeletal research, though controlled human data for the combination remain absent from the published literature.

Source: J Orthop Res (2015) · PubMed

How is peptide purity measured and why does it matter?

Peptide purity is typically assessed by reverse-phase high-performance liquid chromatography (HPLC) and confirmed by mass spectrometry. These techniques quantify the proportion of the target compound relative to impurities such as deletion sequences, oxidized variants, or solvent residues. Research applications require high purity — commonly ≥98% — to ensure that observed biological effects can be attributed to the intended molecule rather than contaminants. Independent third-party certificates of analysis (COAs) provide an objective record of purity at the time of synthesis.

Source: J Pept Sci (2019) · PubMed

What is a Certificate of Analysis (COA)?

A Certificate of Analysis (COA) is a document from an accredited analytical laboratory confirming a compound's identity, purity, and potency. For research peptides it typically includes HPLC chromatograms and mass spectrometry data. Independent third-party COAs are the gold standard for verifying compound quality.

Source: USP General Chapter ⟨1058⟩ · PubMed

View TB-500 in the catalog →